Search
ARS Pharmaceuticals Inc
SPRYAdd to Watchlist
4.150USD
-0.030-0.72%
Close 09-24 16:00（ET）
412.10MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.72%
5 Days
0.00%
1 Month
-22.43%
6 Months
-44.96%
Year to Date
-64.38%
1 Year
-56.91%
Key Figures
4.210Open
4.490High
103.91KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
4.180Prev. Close
4.070Low
428.81KTurnover
51.52P/E Static
32.94P/B
0.00%Div Yield TTM
-64.39%ROA
13.15052wk High
26.68Volume Ratio
8.00MNet Profit
99.30MShares
-2.0023EPS TTM
0.85Beta
-136.40%ROE
4.07052wk Low
10.05%Amplitude
61.83%Gross Margin
412.10MMarket Cap
-2.96Reward/Risk
4.66%Risk Rate
ARS Pharmaceuticals Inc's Score
0.04vs previous score
Forecast9.50
Financial Health7.33
Technical5.26
Valuation Dimensions8.66
Institutional Confidence10.00
Risk Assessment4.07
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
ARS Pharmaceuticals Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
ARS Pharmaceuticals Inc Latest Earnings Call Transcripts
ARS Pharmaceuticals (SPRY) Q2 2026 Earnings Call: neffy Share Gains and Cost Reset
ARS Pharmaceuticals Q2 2026 earnings call: revenue reached $33.7 million as neffy gained share, while management cut costs and targeted 2027 cash break-even.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.63/-0.49
Revenue / Forecast
33.66M/31.32M
ARS Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolSPRY
Number of employees155
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| RA Capital Management, LP | 10.94% |
| Lowenthal (Richard E) | 10.13% |
| OrbiMed Advisors, LLC | 8.35% |
| Deerfield Management Company, L.P. | 7.56% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 29.81% |
| Investment Advisor | 19.03% |
| Investment Advisor/Hedge Fund | 16.80% |
| Venture Capital | 15.02% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of ARS Pharmaceuticals Inc (SPRY)?
The current price of ARS Pharmaceuticals Inc (SPRY) is 4.15.
What is the symbol of ARS Pharmaceuticals Inc?
The ticker symbol of ARS Pharmaceuticals Inc is SPRY.
What is the 52-week high of ARS Pharmaceuticals Inc?
The 52-week high of ARS Pharmaceuticals Inc is 13.15.
What is the 52-week low of ARS Pharmaceuticals Inc?
The 52-week low of ARS Pharmaceuticals Inc is 4.07.
What is the market capitalization of ARS Pharmaceuticals Inc?
The market capitalization of ARS Pharmaceuticals Inc is 412.10M.
Is ARS Pharmaceuticals Inc (SPRY) currently rated as Buy, Hold, or Sell?
According to analysts, ARS Pharmaceuticals Inc (SPRY) has an overall rating of STRONG BUY, with a price target of 26.50.
What is the Earnings Per Share (EPS TTM) of ARS Pharmaceuticals Inc (SPRY)?
The Earnings Per Share (EPS TTM) of ARS Pharmaceuticals Inc (SPRY) is -2.00.